WOW.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Cencora - Wikipedia

    en.wikipedia.org/wiki/Cencora

    AmerisourceBergen was among four companies who, because of their role in the addiction crisis, agreed to pay $260 million to two Ohio counties. [27] In May 2020, Oklahoma Attorney General Mike Hunter sued AmerisourceBergen in Bryan County District Court, Oklahoma. The lawsuit alleged that the company's actions helped fuel Oklahoma's opioid crisis.

  3. Walgreens Boots Alliance - Wikipedia

    en.wikipedia.org/wiki/Walgreens_Boots_Alliance

    Walgreens Boots Alliance, Inc. (WBA) is an American multinational holding company headquartered in Deerfield, Illinois, [2] which owns the retail pharmacy chains Walgreens in the US and Boots in the UK, as well as several pharmaceutical manufacturing and distribution companies. The company was formed on December 31, 2014, after Walgreens bought ...

  4. AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment and new product launches. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...

  5. All You Need to Know About AmerisourceBergen (ABC ... - AOL

    www.aol.com/news/know-amerisourcebergen-abc...

    For premium support please call: 800-290-4726 more ways to reach us

  6. For premium support please call: 800-290-4726 more ways to reach us

  7. Steven H. Collis - Wikipedia

    en.wikipedia.org/wiki/Steven_H._Collis

    1961 or 1962 (age 62–63) [1] South Africa. Title. Chairman, president and CEO, AmerisourceBergen. Predecessor. R. David Yost. Successor. incumbent. Steven H. Collis (born 1961) is an American businessman, the chairman, president and chief executive officer (CEO) of Cencora, previously known as AmerisourceBergen. [2][3][4][5]

  8. Need help? Call us! 800-290-4726 Login / Join. Mail

  9. What's in Store for AmerisourceBergen (ABC) in Q1 Earnings? - AOL

    www.aol.com/news/whats-store-amerisourcebergen...

    AmerisourceBergen's (ABC) Q1 earnings are likely to reflect the better-than-expected performance at Pharmaceutical Distribution and higher revenues.